NFKB1 and metabolic dysfunction-associated steatohepatitis: Reduction of the activity of IKB and RelA and JUN by miR-423-5p may lead to inhibition of the NF-kB pathway and inactivation of pro-apoptotic factors, contributing to the progression of NASH.